Antineoplaston

Results: 8



#Item
1Chapter 10  Laws and Regulations Affecting Unconventional Cancer Treatments  CONTENTS

Chapter 10 Laws and Regulations Affecting Unconventional Cancer Treatments CONTENTS

Add to Reading List

Source URL: www.princeton.edu

Language: English - Date: 1996-11-21 08:14:57
2References  References 1. Abbott, B.J., Developmental Therapeutics Program, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human

References References 1. Abbott, B.J., Developmental Therapeutics Program, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human

Add to Reading List

Source URL: www.princeton.edu

Language: English - Date: 1996-11-21 08:15:11
3Chapter 5  Pharmacologic and Biologic Treatments  CONTENTS

Chapter 5 Pharmacologic and Biologic Treatments CONTENTS

Add to Reading List

Source URL: www.princeton.edu

Language: English - Date: 1996-11-21 08:14:54
4Index  Index 169, 187; see also Journal of the American Medical Association insurance reimbursement and, 187, 189, 191

Index Index 169, 187; see also Journal of the American Medical Association insurance reimbursement and, 187, 189, 191

Add to Reading List

Source URL: www.princeton.edu

Language: English - Date: 1996-11-21 08:15:11
5May_7_13_PRESS_KIT_2013_no_Contact_info

May_7_13_PRESS_KIT_2013_no_Contact_info

Add to Reading List

Source URL: www.burzynskimovie.com

Language: English - Date: 2013-07-02 06:51:43
6P a g e |1  Responses to January 17th to March 15th, 2013 (FDA-483) Inspectional Observations Observation 1 Failure to monitor the progress of an investigation conducted under your IND. Specifically,

P a g e |1 Responses to January 17th to March 15th, 2013 (FDA-483) Inspectional Observations Observation 1 Failure to monitor the progress of an investigation conducted under your IND. Specifically,

Add to Reading List

Source URL: www.burzynskiresearch.com

Language: English - Date: 2013-11-14 10:27:36
7Page |1 Responses to January 7th to March 15th, 2013 (FDA-483) Inspectional Observations Observation 1 An investigation was not conducted in accordance with the signed statement of investigator and investigation plan. Sp

Page |1 Responses to January 7th to March 15th, 2013 (FDA-483) Inspectional Observations Observation 1 An investigation was not conducted in accordance with the signed statement of investigator and investigation plan. Sp

Add to Reading List

Source URL: www.burzynskiclinic.com

Language: English - Date: 2013-11-11 18:52:45
8

PDF Document

Add to Reading List

Source URL: www.fda.gov

Language: English